The IL-13 transcriptional signature can be used to identify individuals with type 2 high and type 2 low asthma; approximately 50% of people with asthma are type 2 high and exhibit worsened AHR to methacholine, higher serum IgE, and eosinophils [67,69]. This evidence concerns the gene IGHE and asthma.